stockportfolio.pro
Stocks / ADPT vs LFST
ADPT vs LFST
Adaptive Biotechnologies Corporation and LifeStance Health Group, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Adaptive Biotechnologies Corporation (ADPT) | LifeStance Health Group, Inc. (LFST) | |
|---|---|---|
| Market cap | $3.0B | $3.0B |
| Revenue (latest FY) | $276.98M | $1.42B |
| Net income (latest FY) | $-59.50M | $9.66M |
| Revenue growth (5y CAGR) | 23.0% | 46.3% |
| Net margin | -21.5% | 0.7% |
| Return on equity | -27.2% | 0.6% |
| P/E ratio | — | 130.3 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 2 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ADPT — free Open LFST — freeFrequently asked questions
Which is bigger, ADPT or LFST?
Adaptive Biotechnologies Corporation is larger by market capitalization — $3.0B versus $3.0B.
Which grows faster, ADPT or LFST?
Over the last five fiscal years, LifeStance Health Group, Inc. grew revenue faster — 46.3%/yr versus 23.0%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.